These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 319291)

  • 1. Digitalis pharmacokinetics and therapy with respect to impaired renal function.
    Kramer P
    Klin Wochenschr; 1977 Jan; 55(1):1-11. PubMed ID: 319291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digitalis therapy in renal failure with special regard to digitoxin.
    Vöhringer HF; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uraemic and normal plasma protein binding of various cardiac glycosides under "in vivo" conditions.
    Kramer P; Köthe E; Scheler F
    Eur J Clin Invest; 1974 Feb; 4(1):53-8. PubMed ID: 4819835
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dialysis and per cent elimination of different cardiac glycosides during haemo- and peritonealdialysis].
    Kramer P; Quellhorst E; Horenkamp J; Scheler F
    Klin Wochenschr; 1972 Jun; 50(12):609-13. PubMed ID: 5052656
    [No Abstract]   [Full Text] [Related]  

  • 5. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digitalis pharmacokinetics and metabolism.
    Marcus FI
    Am J Med; 1975 Apr; 58(4):452-9. PubMed ID: 1092160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of cardiac glycosides through hemofiltration.
    Kramer P; Matthias C; Matthaei D; Scheler F
    J Dial; 1977; 1(7):689-95. PubMed ID: 608877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum half-life and renal clearance of 3H peruvoside. Study on normal persons and patients with terminal kidney insufficiency].
    Kramer P; Willms B; Horenkamp J; Scheler F
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():440-4. PubMed ID: 5380625
    [No Abstract]   [Full Text] [Related]  

  • 9. Inotropic action, myocardial uptake and subcellular distribution of ouabain, digoxin and digitoxin in isolated rat hearts.
    Fricke U; Hollborn U; Klaus W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):195-214. PubMed ID: 1161045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal elimination kinetics of various several cardiac glycosides].
    Kramer P; Scheler F
    Dtsch Med Wochenschr; 1972 Oct; 97(40):1485-90. PubMed ID: 5071762
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolism of cardioactive glycosides].
    Vergassola R
    Clin Ter; 1971 Apr; 57(2):171-84. PubMed ID: 5165081
    [No Abstract]   [Full Text] [Related]  

  • 12. [Concentration of cardiac glycosides in the heart and brain (author's transl)].
    Flasch H; Heinz N
    Arzneimittelforschung; 1976; 26(6):1213-6. PubMed ID: 989419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effective concentration and dosage for cardiac glycosides].
    Weiss M; Förster W
    Z Gesamte Inn Med; 1980 Jan; 35(1):1-7. PubMed ID: 6996345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digitalis in chronic renal insufficiency.
    Rambausek M; Ritz E
    Blood Purif; 1985; 3(1-3):4-14. PubMed ID: 3006726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides.
    Smith TW
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):43A-50A. PubMed ID: 3921586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentration, uptake by liver, and biliary excretion of tritiated cardiac glycosides in the isolated perfused guinea-pig liver.
    Kolenda KD; Lüllmann H; Peters T; Seiler KU
    Br J Pharmacol; 1971 Apr; 41(4):648-60. PubMed ID: 5579463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-related alterations in cardiac glycoside disposition.
    Ochs HR; Greenblatt DJ; Bodem G; Dengler HJ
    Clin Pharmacokinet; 1982; 7(5):434-51. PubMed ID: 6754209
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the problem of cardiac glycoside accumulation].
    Kuschinsky K
    Dtsch Med Wochenschr; 1968 Nov; 93(48):2344-7. PubMed ID: 4881347
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiac glycoside receptor affinity and (Na++K+)-ATPase inhibition of digitoxin, digoxin, methyldigoxin, strophanthin, proscillaridin, and meproscillarin. Measurements on isolated human cardiac cell membranes].
    Erdmann E
    Arzneimittelforschung; 1978; 28(3a):531-5. PubMed ID: 148278
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacokinetics of cardiac glycosides and clinical consequences].
    Rietbrock N; Kuhlmann J; Vöhringer HF
    Fortschr Med; 1977 Apr; 95(14):909-15, 951-4. PubMed ID: 856698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.